Medical Writers News Hubb
Advertisement Banner
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home News

Belimumab Is Efficacious For Lupus Nephritis In East Asian Adults

admin by admin
September 3, 2022
in News



This prespecified subgroup analysis of East Asian adults who participated in a phase 3 clinical trial of belimumab added to standard therapy vs. placebo added to standard therapy for lupus nephritis shows earlier and more sustained improvement in kidney outcomes with the addition of belimumab.

Lupus nephritis (LN) is a severe complication of the kidneys in patients with the autoimmune disease systemic lupus erythematosus. Belimumab is used in combination with standard therapy for treatment of patients with LN. As data on belimumab treatment of East Asian patients with LN are limited, researchers assessed the efficacy and safety of belimumab in a subgroup of East Asian patients from the BLISS-LN, a randomized controlled trial. Patients received monthly belimumab or placebo in addition to standard therapy.

After 104 weeks, patients who received belimumab showed earlier and more sustained improvements in kidney outcomes compared with patients who received placebo, while no new safety concerns were raised. These results recently published in the American Journal of Kidney Diseases (AJKD) support the use of belimumab treatment for East Asian patients with LN.

Source:

National Kidney Foundation

Journal reference:

10.1053/j.ajkd.2022.06.013



Source link

Tags: Clinical TrialEfficacyKidneyLupusNephritisPlacebo
Previous Post

R.R. Donnelly & Sons accelerates COVID-19 test delivery to U.S.

Next Post

DeviceTalks West 2022 is focused on the future

Next Post

DeviceTalks West 2022 is focused on the future

Recommended

Proofreading Tips for Busy Medical Communicators

3 weeks ago

Why Medtronic’s paying up to $1B for Affera’s cardiac ablation tech

2 months ago

Wellness Tips to Avoid Burnout

2 weeks ago

How Cala Health’s wrist-worn Trio device treats essential tremors

4 months ago

MIT engineers fabricate chip-free, wireless e-skin

6 months ago

Almost a third of patients with chronic pain use cannabis

4 weeks ago

Medical-Writers-(-white-)

© 2022 Medical Writers News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Papers
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Papers
  • Contact

© 2022 Medical Writers News Hubb All rights reserved.